Tribune News Service
Chandigarh, June 14
The Food and Drug Administration (FDA), Punjab, and Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, have signed a memorandum of understanding (MoU) to strengthen the implementation of trans-fat regulation in the state.
Advertisement
Signing the MoU, Kumar Rahul, Commissioner, FDA, said: “Excessive use of trans fats is one of the leading risk factors of Covid-related mortalities in the state.”
Advertisement
×
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Combo
Yearly
Monthly
Already a Member? Sign In Now
Advertisement
Advertisement
Advertisement